Tags : 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

Tuba Khan June 15, 2021

Event description: Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th June – 1st July 2021 would address the challenges and future directions in […]readmore

Tags : 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company